Leap Therapeutics Inc.
LPTX | NASDAQ
$0.77
-$0.02 (-3.10%)
At close: Apr 01, 2026, 09:30 AM ET
Market Data
Market Cap $31.86M
Enterprise Value $24.27M
Beta 0.09
Average Volume N/A
Shares Outstanding (Diluted) 176.26M
Shares Change YoY 325.29%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 141.1%
1Y CAGR (ann.) -46.2%
5Y CAGR (ann.) -39.7%
All-Time CAGR -35.0%
Valuation
PE Ratio 1.22
Forward PE 2.65
PEG Ratio -0.00
Forward PEG -0.00
PS Ratio 152.42
Forward PS 0.50
PB Ratio 0.23
P/FCF Ratio -0.50
P/Adj. FCF Ratio -0.46
P/OCF Ratio -2.08
EV/Sales 116.12
EV/EBIT -1.85
EV/EBITDA -1.37
EV/FCF -0.38
Earnings Yield 81.8%
FCF Yield -200.4%
Adj. FCF Yield -219.4%
Financial Health
Net Cash $7.59M
Total Debt $38K
Cash & Short-Term Investments $7.62M
Total Assets $142.97M
Current Ratio 79.19
Quick Ratio 79.19
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -1,733.16
Interest Coverage 8,887.50
Altman Z-Score 1.18
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin -9631.6%
Operating Profit Margin -8504.8%
EBITDA Margin -8504.8%
Net Profit Margin 17655.5%
FCF Margin -30551.2%
Adj. FCF Margin -33447.4%
SBC / Revenue 2896.2%
SBC Impact (per share) -9.5%
Returns
Return on Assets 25.8%
Return on Equity 23.8%
Return on Invested Capital -12.6%
Return on Capital Employed -12.6%
Return on Tangible Assets 25.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -60.7%
Revenue CAGR 5Y -51.4%
Revenue CAGR 10Y -1.3%
EPS CAGR 3Y 133.7%
EPS CAGR 5Y 55.5%
EPS CAGR 10Y 32.4%
FCF CAGR 3Y -11.9%
FCF CAGR 5Y -10.3%
FCF CAGR 10Y -10.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y -45.3%
Revenue Growth Next 3Y 473.5%
Earnings Date May 17, 2026
EPS Estimate (next Q) -$0.04
EPS Growth Est (next Q) -89.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number $3.35
Graham Upside 335.1%
Lynch Fair Value $15.75
Lynch Upside 1945.5%
Price Target $5.50
Price Target Upside 614.3%
Cash Flow
Operating Cash Flow $-65.86M
Free Cash Flow $-63.85M
Adj. Free Cash Flow $-69.91M
FCF Per Share -$0.36
OCF Per Share -$0.37
OCF/S Ratio -31512.0%
Income Statement
Revenue $209K
Gross Profit $-20.13M
Operating Income $-17.78M
EBITDA $-17.78M
Net Income $36.9M
EPS (Diluted) $0.63
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove LPTX